Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
about
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older PeopleA Systematic Review on the Effects of Botanicals on Skeletal Muscle Health in Order to Prevent SarcopeniaEffects of whole body vibration training on body composition, skeletal muscle strength, and cardiovascular healthPharmacological perspectives in sarcopenia: a potential role for renin-angiotensin system blockers?Maximising functional recovery following hip fracture in frail seniorsMeasurement of body composition as a surrogate evaluation of energy balance in obese patientsDeterminants of Muscle and Bone AgingMeasures of frailty in population-based studies: an overviewMitochondria in the Aging Muscles of Flies and Mice: New Perspectives for Old CharactersOxidative system in aged skeletal muscleVitamin E in sarcopenia: current evidences on its role in prevention and treatmentChanges in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restrictionHow pleiotropic genetics of the musculoskeletal system can inform genomics and phenomics of agingEpidemiology of sarcopenia and insight into possible therapeutic targets.Physical frailty, sarcopenia, and the enablement of autonomy: philosophical issues in geriatric medicine.Prevalence of sarcopenia in older Brazilians: A systematic review and meta-analysis.Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium.Elderly Mexicans have less muscle and greater total and truncal fat compared to African-Americans and Caucasians with the same BMI.Handgrip strength and mortality in the oldest old population: the Leiden 85-plus studyAbdominal Fat and Sarcopenia in Women Significantly Alter Osteoblasts Homeostasis In Vitro by a WNT/ β -Catenin Dependent Mechanism.Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations.Anabolic and catabolic biomarkers as predictors of muscle strength decline: the InCHIANTI studyShorter telomeres in peripheral blood mononuclear cells from older persons with sarcopenia: results from an exploratory studyLongitudinal impact of aging on muscle quality in middle-aged menOptimal management of sarcopenia.Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update.Nutritional recommendations for the management of sarcopenia.Long-term wheel running changes on sensorimotor activity and skeletal muscle in male and female mice of accelerated senescence.Osteosarcopenic obesity: the role of bone, muscle, and fat on healthSarcopenia with limited mobility: an international consensus.Borderlines between Sarcopenia and Mild Late-Onset Muscle Disease.Comparison of quadriceps strength and handgrip strength in their association with health outcomes in older adults in primary care.Dorsal muscle group area and surgical outcomes in liver transplantationCorrelation between muscle strength and muscle mass, and their association with walking speed, in community-dwelling elderly Japanese individuals.Exercise attenuates the major hallmarks of aging.Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014.Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging.The significance of body mass index in calculating the cut-off points for low muscle mass in the elderly: methodological issues.The effect of diabetes mellitus on age-associated lean mass loss in 3153 older adults
P2860
Q24633789-EBF86F1C-AAFC-4E00-8E54-C0BA6EA6DF31Q26751213-1C8553DF-BC04-4AC4-9221-6555015B89F0Q26771043-EDAC664F-E2D8-4A89-8558-55CEC0F1760CQ26775758-1CF31ACB-A608-4934-8DEA-7793B6A983DAQ26824069-751D36DA-E4AF-4D0A-94BB-E61C8150BD27Q26862846-F2251379-C6D0-43AD-A13C-226B02834814Q26998480-C56E799A-2686-4D57-9F52-D5D262F3EEDAQ27027509-2A3F5D10-C2E7-4937-870D-8CEF2C442643Q28074180-FDA72316-9DEB-4ECD-A93D-6A87F298118BQ28383588-C8C6871C-8185-41DE-8EDE-196A0E342B08Q28390862-E43C2934-F79B-44CC-8107-2761D0659E60Q28569873-E103B10F-9859-4910-8937-AE79779075ABQ28741685-A97F724A-45E0-4886-A8A6-10D74A330E66Q30234579-CCC6CAD3-1014-4DA0-9C0A-1CD238FE18DCQ30235967-FF93BA85-190E-4876-BF0F-5FE84D549896Q30251945-0BB118EF-5C1A-4B5F-AC39-16FA9421FC88Q33349016-D350AD53-6CA6-46E7-A319-4D17A1295D46Q33610976-5A5F326C-FDBE-4952-B5D3-0B9610CE732AQ33643704-7533D4EE-05C2-460F-B4F9-23A1A57A2827Q33743445-EBF47254-B3AC-497C-B566-EE0D0AD497ACQ33744727-FB7A4593-B683-4501-B943-B1FF97B6EAADQ33828935-238F1DE2-0DEB-4A32-9185-8266F5595C32Q33905135-69CF184D-E4DB-446B-A2A2-6241C9DB98F2Q34102906-FAEFC079-6C28-4D6F-8FE1-4F5519F5ECC8Q34115979-672BAED4-6989-451B-AE74-85D936D0FBD8Q34121822-22144492-EB73-4521-93E5-812F042A6720Q34121836-1CFEDF94-6CFA-4411-871A-A852570359E0Q34125804-73AA954E-06FF-4023-8988-A489CB49DACCQ34156856-FD86523E-2411-4386-99DB-CE4E67DAF48FQ34156977-B5DB10AD-9045-4FEE-B244-340534E0277CQ34189767-58E67372-1CFF-401F-B197-36A4145832A5Q34264679-69004244-50DC-4A89-AA47-28898A9470DAQ34288281-89CD4FBC-5A4A-4480-92C5-77962C7426BDQ34381314-E5186755-06DF-4A96-AC16-DD543072D72EQ34445820-D9B6E166-4E83-44A5-B0CC-71377DAB089AQ34449998-B414B4F4-F58B-4D54-991F-D0AB0AE7E0C7Q34591010-776F59FE-7FE2-4330-B4BD-67D94FC107B1Q34613904-D155365D-97BD-4E4B-BA66-9ED882343816Q34660513-4D609022-279B-4A92-98B9-4A2EF7E899E1Q34690558-80B2E9E8-B64B-4763-B159-41AB777945CC
P2860
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
@en
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives.
@nl
type
label
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
@en
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives.
@nl
prefLabel
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
@en
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives.
@nl
P2093
P2860
P356
P1476
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
@en
P2093
G Abellan Van Kan
J E Morley
R Baumgartner
S Czerwinski
W M C Chumlea
P2860
P2888
P304
P356
10.1007/BF02982704
P577
2008-08-01T00:00:00Z